{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:18:43Z","timestamp":1782944323092,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:00:00Z","timestamp":1396656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s40264-014-0154-y","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T03:24:12Z","timestamp":1396581852000},"page":"309-316","source":"Crossref","is-referenced-by-count":7,"title":["Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease"],"prefix":"10.1007","volume":"37","author":[{"given":"Jaroslaw","family":"Kierkus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Oracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Korczowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wiernicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Woynarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,5]]},"reference":[{"key":"154_CR1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0889-8553(05)70099-6","volume":"28","author":"SR Orenstein","year":"1999","unstructured":"Orenstein SR, Izadnia F, Khan S. Gastroesophageal reflux disease in children. Gastroenterol Clin N Am. 1999;28:947\u201369.","journal-title":"Gastroenterol Clin N Am."},{"issue":"Suppl 8A","key":"154_CR2","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1016\/S0002-9343(01)00861-0","volume":"111","author":"RF Yellon","year":"2001","unstructured":"Yellon RF, Goldberg H. Update on gastroesophageal reflux disease in pediatric airway disorders. Am J Med. 2001;111(Suppl 8A):78S\u201384S.","journal-title":"Am J Med"},{"key":"154_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MPG.0b013e31812e0149","volume":"45","author":"JJ Barron","year":"2007","unstructured":"Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000323619","volume":"57","author":"C Chiesa","year":"2011","unstructured":"Chiesa C, Anania C, Pacifico L, Olivero G, Osborn JF. Helicobacter pylori therapy in children: a focus on proton pump inhibitors. Chemotherapy. 2011;57:85\u201393.","journal-title":"Chemotherapy"},{"key":"154_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00128072-200305010-00003","volume":"5","author":"TE Gibbons","year":"2003","unstructured":"Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs. 2003;5:25\u201340.","journal-title":"Paediatr Drugs"},{"key":"154_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12519-013-0405-5","volume":"9","author":"H Turk","year":"2013","unstructured":"Turk H, Hauser B, Brecelj J, Vandenplas Y, Orel R. Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children. World J Pediatr. 2013;9:36\u201341.","journal-title":"World J Pediatr"},{"key":"154_CR7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jpeds.2006.08.078","volume":"150","author":"E Hassall","year":"2007","unstructured":"Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11\u00a0years duration. J Pediatr. 2007;150:262\u20137.","journal-title":"J Pediatr"},{"key":"154_CR8","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","volume":"117","author":"RB Canani","year":"2006","unstructured":"Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117:e817\u201320.","journal-title":"Pediatrics"},{"key":"154_CR9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","volume":"292","author":"RJ Laheij","year":"2004","unstructured":"Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955\u201360.","journal-title":"JAMA"},{"key":"154_CR10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00005176-200211000-00013","volume":"35","author":"DS Pashankar","year":"2002","unstructured":"Pashankar DS, Israel DM. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr. 2002;35:658\u201362.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"154_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.2001.00115.x","volume":"15","author":"GN Tytgat","year":"2001","unstructured":"Tytgat GN. Review article: long-term use of proton pump inhibitors in GORD\u2014help or hindrance? Aliment Pharmacol Ther. 2001;15(Suppl 2):6\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"154_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"KR DeVault","year":"2005","unstructured":"DeVault KR, Castell DO, American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190\u2013200.","journal-title":"Am J Gastroenterol"},{"key":"154_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/157488411794941296","volume":"6","author":"C Romano","year":"2011","unstructured":"Romano C, Chiaro A, Comito D, Loddo I, Ferrau V. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. Curr Clin Pharmacol. 2011;6:41\u20137.","journal-title":"Curr Clin Pharmacol"},{"key":"154_CR14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2010-2719","volume":"127","author":"RJ Pol van der","year":"2011","unstructured":"van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics. 2011;127:925\u201335.","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"154_CR15","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00005176-200311001-00011","volume":"37","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Winter HS. Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. J Pediatr Gastroenterol Nutr. 2003;37(Suppl 1):S52\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 3","key":"154_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","volume":"13","author":"T Ishizaki","year":"1999","unstructured":"Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2014emphasis on rabeprazole. Aliment Pharmacol Ther. 1999;13(Suppl 3):27\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"154_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","volume":"37","author":"SN Wildt de","year":"1999","unstructured":"de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 1999;37:485\u2013505.","journal-title":"Clin Pharmacokinet"},{"key":"154_CR18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00008571-199712000-00002","volume":"7","author":"JM Treluyer","year":"1997","unstructured":"Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo\/in-vitro correlation and inducibility. Pharmacogenetics. 1997;7:441\u201352.","journal-title":"Pharmacogenetics"},{"key":"154_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpeds.2009.02.025","volume":"155","author":"T Omari","year":"2009","unstructured":"Omari T, Lundborg P, Sandstrom M, Bondarov P, Fjellman M, Haslam R, et al. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. J Pediatr. 2009;155:222\u20138.","journal-title":"J Pediatr"},{"key":"154_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11591900-000000000-00000","volume":"50","author":"BK Tammara","year":"2011","unstructured":"Tammara BK, Sullivan JE, Adcock KG, Kierkus J, Giblin J, Rath N, et al. Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1\u00a0month through <6\u00a0years with gastro-oesophageal reflux disease. Clin Pharmacokinet. 2011;50:541\u201350.","journal-title":"Clin Pharmacokinet"},{"key":"154_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00148581-200810040-00005","volume":"10","author":"W Zhang","year":"2008","unstructured":"Zhang W, Kukulka M, Witt G, Sutkowski-Markmann D, North J, Atkinson S. Age-dependent pharmacokinetics of lansoprazole in neonates and infants. Paediatr Drugs. 2008;10:265\u201374.","journal-title":"Paediatr Drugs"},{"key":"154_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10620-010-1321-3","volume":"56","author":"J Kierkus","year":"2011","unstructured":"Kierkus J, Furmaga-Jablonska W, Sullivan JE, David ES, Stewart DL, Rath N, et al. Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11\u00a0months with a clinical diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 2011;56:425\u201334.","journal-title":"Dig Dis Sci"},{"key":"154_CR23","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1111\/j.1572-0241.2000.03256.x","volume":"95","author":"T Andersson","year":"2000","unstructured":"Andersson T, Hassall E, Lundborg P, Shepherd R, Radke M, Marcon M, et al. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group. Am J Gastroenterol. 2000;95:3101\u20136.","journal-title":"Am J Gastroenterol"},{"key":"154_CR24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2007.09.007","volume":"29","author":"L James","year":"2007","unstructured":"James L, Walson P, Lomax K, Kao R, Varughese S, Reyes J, et al. Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16\u00a0years with gastroesophageal reflux disease: an open-label, single- and multiple-dose study. Clin Ther. 2007;29:2082\u201392.","journal-title":"Clin Ther"},{"key":"154_CR25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1542\/peds.2007-1146","volume":"120","author":"V Khoshoo","year":"2007","unstructured":"Khoshoo V, Edell D, Thompson A, Rubin M. Are we overprescribing antireflux medications for infants with regurgitation? Pediatrics. 2007;120:946\u20139.","journal-title":"Pediatrics"},{"key":"154_CR26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MPG.0b013e31812e012f","volume":"45","author":"T Omari","year":"2007","unstructured":"Omari T, Davidson G, Bondarov P, Naucler E, Nilsson C, Lundborg P. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1\u201324\u00a0months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;45:530\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","volume":"154","author":"SR Orenstein","year":"2009","unstructured":"Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514\u201320.","journal-title":"J Pediatr"},{"key":"154_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00148581-200810040-00004","volume":"10","author":"M Springer","year":"2008","unstructured":"Springer M, Atkinson S, North J, Raanan M. Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1\u00a0year. Paediatr Drugs. 2008;10:255\u201363.","journal-title":"Paediatr Drugs"},{"key":"154_CR29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","volume":"50","author":"H Winter","year":"2010","unstructured":"Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1\u201311\u00a0months old with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2010;50:609\u201318.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004836-198306000-00009","volume":"5","author":"RW Sherbaniuk","year":"1983","unstructured":"Sherbaniuk RW, Wensel R, Trautman A, Grace M, Lentle B, Walker K, et al. Gastrin, gastric emptying, and gastroesophageal reflux after ranitidine. J Clin Gastroenterol. 1983;5:239\u201344.","journal-title":"J Clin Gastroenterol"},{"key":"154_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MPG.0b013e31829b6914","volume":"57","author":"W Treem","year":"2013","unstructured":"Treem W, Hu P, Sloan S. Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11\u00a0months old. J Pediatr Gastroenterol Nutr. 2013;57:520\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/S0022-3476(03)00207-5","volume":"143","author":"DJ Moore","year":"2003","unstructured":"Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:219\u201323.","journal-title":"J Pediatr"},{"key":"154_CR33","first-page":"A-444","volume":"136","author":"G Comer","year":"2009","unstructured":"Comer G, Baker R, Tsou V, et al. Randomized, double-blind clinical outcomes, safety, and tolerability study of pantoprazole delayed-release granules in children aged 1 to 5\u00a0years with endoscopically proven symptomatic gastroesophageal reflux disease (GERD). Gastroenterology. 2009;136:A-444 Abstract M1909.","journal-title":"Gastroenterology"},{"issue":"1","key":"154_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MPG.0b013e3182496b35","volume":"55","author":"H Winter","year":"2012","unstructured":"Winter H, Gunasekaran T, Tolia V, et al. Esomeprazole for the treatment of GERD in infants ages 1\u201311\u00a0months. J Pediatr Gastroenterol Nutr. 2012;55(1):14\u201320.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0b013e31819de871","volume":"49","author":"Y Vandenplas","year":"2009","unstructured":"Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49:498\u2013547.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.mpg.0000252190.97545.07","volume":"44","author":"TI Omari","year":"2007","unstructured":"Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007;44:41\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR37","doi-asserted-by":"crossref","unstructured":"Hussain S, Kierkus J, Hu P, Hoffman D, Lekich R, Sloan S, et al. Safety and efficacy of delayed release rabeprazole in 1 to 11\u00a0month-old infants with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2014;58(2):233\u201343.","DOI":"10.1097\/MPG.0000000000000195"},{"key":"154_CR38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/000992289603501201","volume":"35","author":"SR Orenstein","year":"1996","unstructured":"Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the Infant Gastroesophageal Reflux Questionnaire. Clin Pediatr (Phila). 1996;35:607\u201314.","journal-title":"Clin Pediatr (Phila)"},{"key":"154_CR39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.110.5.972","volume":"110","author":"S Salvatore","year":"2002","unstructured":"Salvatore S, Vandenplas Y. Gastroesophageal reflux and cow milk allergy: is there a link? Pediatrics. 2002;110:972\u201384.","journal-title":"Pediatrics"},{"key":"154_CR40","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","volume":"99","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett\u2019s esophagus. Am J Gastroenterol. 2004;99:1877\u201383.","journal-title":"Am J Gastroenterol"},{"key":"154_CR41","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ajg.2009.129","volume":"104","author":"PM Sherman","year":"2009","unstructured":"Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, Koletzko S, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009;104:1278\u201395.","journal-title":"Am J Gastroenterol"},{"key":"154_CR42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","volume":"24","author":"E Bjornsson","year":"2006","unstructured":"Bjornsson E, Abrahamsson H, Simren M, Mattsson N, Jensen C, Agerforz P, et al. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2006;24:945\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"154_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2036.2004.02271.x","volume":"21","author":"R Fossmark","year":"2005","unstructured":"Fossmark R, Johnsen G, Johanessen E, Waldum HL. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther. 2005;21:149\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"154_CR44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MPG.0b013e3182a4e718","volume":"57","author":"I Haddad","year":"2013","unstructured":"Haddad I, Kierkus J, Tron E, Ulmer A, Hu P, Sloan S, et al. Efficacy and safety of rabeprazole in children (1\u201311\u00a0years) with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2013;57:798\u2013807.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR45","doi-asserted-by":"crossref","unstructured":"Haddad I, Kierkus J, Tron E, Ulmer A, Hu P, Silber S, et al. Maintenance of efficacy and safety of rabeprazole in children aged 1\u201311\u00a0years with endoscopically proven GERD. J Pediatr Gastroenterol Nutr. 2014;58(4):510\u20137.","DOI":"10.1097\/MPG.0000000000000229"},{"key":"154_CR46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPG.0b013e31815667d7","volume":"46","author":"V Khoshoo","year":"2008","unstructured":"Khoshoo V, Dhume P. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2008;46:352\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"154_CR47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0b013e318176b2cb","volume":"46","author":"MA Gilger","year":"2008","unstructured":"Gilger MA, Tolia V, Vandenplas Y. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2008;46(5):524\u201333.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR48","first-page":"304","volume":"28","author":"O Borrelli","year":"2002","unstructured":"Borrelli O, Rea P, de Bueno M, et al. Efficacy of combined administration of an alginate formulation (Gaviscon) and lansoprazole for children with gastroesophageal reflux disease. Ital J Pediatr. 2002;28:304\u20139.","journal-title":"Ital J Pediatr"},{"key":"154_CR49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1572-0241.2007.01152.x","volume":"102","author":"G Boccia","year":"2007","unstructured":"Boccia G, Manguso F, Miele E, Buonavolonta R, Staiano A. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Am J Gastroenterol. 2007;102:1291\u20137.","journal-title":"Am J Gastroenterol"},{"key":"154_CR50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/adc.69.6.655","volume":"69","author":"S Cucchiara","year":"1993","unstructured":"Cucchiara S, Minella R, Iervolino C, Franco MT, Campanozzi A, Franceschi M, et al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch Dis Child. 1993;69:655\u20139.","journal-title":"Arch Dis Child"},{"key":"154_CR51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.mpg.0000214160.37574.d3","volume":"42","author":"V Tolia","year":"2006","unstructured":"Tolia V, Bishop PR, Tsou VM, Gremse D, Soffer EF, Comer GM, et al. Multicenter, randomized, double-blind study comparing 10, 20 and 40\u00a0mg pantoprazole in children (5\u201311\u00a0years) with symptomatic gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2006;42:384\u201391.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MPG.0b013e318148c17c","volume":"45","author":"BD Gold","year":"2007","unstructured":"Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, et al. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;45:520\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"154_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0009922806292792","volume":"45","author":"VM Tsou","year":"2006","unstructured":"Tsou VM, Baker R, Book L, Hammo AH, Soffer EF, Wang W, et al. Multicenter, randomized, double-blind study comparing 20 and 40\u00a0mg of pantoprazole for symptom relief in adolescents (12 to 16\u00a0years of age) with gastroesophageal reflux disease (GERD). Clin Pediatr (Phila). 2006;45:741\u20139.","journal-title":"Clin Pediatr (Phila)"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-014-0154-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0154-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:32Z","timestamp":1559490092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-014-0154-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1007\/s40264-014-0154-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,5]]}}}